🔗 Visit the ClinicalTrials.gov page for NCT00001705
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. | Nat Med | 1998 | 11.03 |
| 2 | Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. | JAMA | 1994 | 6.36 |
| 3 | Cancer vaccines based on the identification of genes encoding cancer regression antigens. | Immunol Today | 1997 | 2.89 |